Welcome to our dedicated page for EXPONENT SEC filings (Ticker: EXPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Exponent Inc filings document operating results, Regulation FD disclosures, capital-return actions, and governance matters for a science and engineering consulting company. Recent Form 8-K reports record quarterly financial results, dividend declarations, and share repurchase authorizations tied to the company’s common stock.
Proxy materials cover shareholder voting matters, director elections, executive compensation, pay-versus-performance tables, and board governance. The filing record also includes material-event disclosures related to leadership and corporate governance, along with capital-structure disclosures relevant to Exponent’s public-company reporting.
Morgan Stanley Smith Barney LLC filed a Form 144 reporting a proposed sale of Common Stock of EXPO with a filing date of 05/13/2026. The filing lists two blocks of restricted stock dated 03/11/2026 and 03/11/2022.
Morgan Stanley Smith Barney LLC submitted a Form 144 relating to EXPO Common stock. The filing, dated 05/13/2026, lists proposed sales of Common shares identified as restricted stock including 986 shares issued 03/11/2026 and 1,080 shares issued 03/11/2022. The filing names NASDAQ as the market.
Exponent Inc Chief Financial Officer Eric R. Anderson filed an initial statement of beneficial ownership. He directly holds 2,955 shares of common stock. He also holds restricted stock units covering 4,750, 3,628, 3,538 and 3,000 shares of common stock on a 1-for-1 basis, plus options for 6,592 shares at an exercise price of $65.56 and 6,008 shares at $66.56 that become exercisable in four equal annual installments and expire in 2036.
Exponent, Inc. reported first-quarter 2026 revenue of $166.3 million, up 14.3% from $145.5 million a year earlier, driven by strong Engineering and Other Scientific work and AI-related user research and utility risk management projects. Revenues before reimbursements rose 10% to $151.8 million.
Net income increased 11% to $29.6 million, with diluted EPS rising to $0.59 from $0.52. EBITDA reached $43.1 million, and EBITDA as a percentage of revenues before reimbursements improved to 28.4%. The company returned capital through a $0.31 per-share dividend, Q1 share repurchases of about $78.8 million, and a new $50 million buyback authorization.
Exponent, Inc. reported solid first quarter 2026 results, with total revenues rising 14% to $166.3 million and revenues before reimbursements up 10% to $151.8 million versus the prior-year period. Net income increased to $29.6 million, or $0.59 per diluted share, compared to $26.7 million, or $0.52 per diluted share.
EBITDA grew to $43.1 million, representing a margin of 28.4% of net revenues, up from 27.3%. The company ended the quarter with $118.6 million in cash and cash equivalents after paying $16.6 million in dividends and repurchasing $78.8 million of stock.
The Board declared a regular quarterly dividend of $0.31 per share payable on June 18, 2026, to holders of record on June 5, 2026, and increased the stock repurchase authorization by $50 million, in addition to $17.7 million already available. Exponent expects high-single-digit growth in revenues before reimbursements and EBITDA margins in the high-20% range for the second quarter and full year 2026.
Exponent Inc Schedule 13G: Vanguard Capital Management reports beneficial ownership of 2,586,291 shares of Common Stock, representing 5.25% of the class as of 03/31/2026. The filing shows sole dispositive power over 2,586,291 shares and sole voting power for 375,641 shares. The disclosure states these holdings include securities held by Vanguard funds and managed accounts for which Vanguard Capital Management LLC and specified affiliates exercise dispositive or voting power.
Vanguard Portfolio Management reported beneficial ownership of 2,990,195 shares of Exponent Inc common stock, representing 6.07% of the class as of 03/31/2026. The filing (Schedule 13G) shows sole voting power over 43,439 shares and sole dispositive power over 2,990,195 shares. The report states these holdings include securities held for Vanguard funds and managed accounts where dispositive power is exercised by Vanguard Portfolio Management. The form is signed by Ashley Grim on 04/29/2026.
Exponent, Inc. is asking stockholders to vote at its virtual 2026 annual meeting on three items: electing six directors for one-year terms, ratifying KPMG LLP as auditor for the year ending January 1, 2027, and approving 2025 executive pay on an advisory basis.
The company describes its board structure, committee responsibilities, director independence, and director pay, including cash retainers and annual restricted stock units. It also highlights planned leadership changes effective May 1, 2026, with John D. Pye becoming President and Eric Anderson becoming Chief Financial Officer, while Catherine Ford Corrigan remains Chief Executive Officer and Richard L. Schlenker continues as Executive Vice President.
Exponent Inc. President & CEO Catherine Corrigan reported a series of option exercises combined with share sales. On March 16 and April 15, she exercised options covering a total of 11,211 shares of common stock at exercise prices of $25.405 and $29.05 per share.
Across the same dates, she sold 7,821 shares in open-market transactions at prices around $67.49–$67.70 per share and retained the remainder. Following these transactions, Corrigan holds 104,359 shares of Exponent common stock directly.